Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 73,242 | 65,562 | 53,303 | 41,815 | 31,717 |
| Cost of Goods | 16,892 | 15,404 | 12,021 | 9,765 | 8,143 |
| Gross Profit | 56,350 | 50,158 | 41,282 | 32,050 | 23,574 |
| Operating Expenses | 35,277 | 30,527 | 25,676 | 22,997 | 24,474 |
| Operating Income | 21,965 | 20,036 | 15,628 | 9,818 | -756 |
| Other Income | 2,311 | 1,703 | 553 | 19 | 139 |
| Pre-tax Income | 24,276 | 21,738 | 16,181 | 9,836 | -617 |
| Income Tax | 5,041 | 4,546 | 3,352 | 511 | -1,986 |
| Net Income Continuous | 19,234 | 17,193 | 12,829 | 9,326 | 1,369 |
| Net Income | $19,234 | $17,193 | $12,829 | $9,326 | $1,369 |
| EPS Basic Total Ops | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 |
| EPS Basic Continuous Ops | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 |
| EPS Diluted Total Ops | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 |
| EPS Diluted Continuous Ops | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 |
| EPS Diluted Before Non-Recurring Items | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 |
| EBITDA(a) | $22,782 | $20,801 | $16,298 | $11,225 | $583 |